C07D 295/145
With the ring nitrogen atoms and the carbon atoms with three bonds
Official title: with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
C07D295/145 (With the ring nitrogen atoms and the carbon atoms with three bonds) appears on 934 US grants and 737 published applications in this corpus.
Search patents in C07D- Granted patents
- 934
- Published applications
- 737
- Assignees
- 518
- Inventors
- 2,659
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 24 | 0 |
| 1978 | 22 | 0 |
| 1979 | 21 | 0 |
| 1980 | 19 | 0 |
| 1981 | 25 | 0 |
| 1982 | 14 | 0 |
| 1983 | 13 | 0 |
| 1984 | 18 | 0 |
| 1985 | 10 | 0 |
| 1986 | 11 | 0 |
| 1987 | 8 | 0 |
| 1988 | 12 | 0 |
| 1989 | 16 | 0 |
| 1990 | 10 | 0 |
| 1991 | 11 | 0 |
| 1992 | 9 | 0 |
| 1993 | 15 | 0 |
| 1994 | 16 | 0 |
| 1995 | 23 | 0 |
| 1996 | 18 | 0 |
| 1997 | 28 | 0 |
| 1998 | 22 | 0 |
| 1999 | 18 | 0 |
| 2000 | 17 | 0 |
| 2001 | 23 | 4 |
| 2002 | 29 | 27 |
| 2003 | 15 | 35 |
| 2004 | 22 | 36 |
| 2005 | 20 | 32 |
| 2006 | 21 | 28 |
| 2007 | 20 | 32 |
| 2008 | 12 | 29 |
| 2009 | 25 | 30 |
| 2010 | 15 | 18 |
| 2011 | 17 | 26 |
| 2012 | 18 | 28 |
| 2013 | 28 | 28 |
| 2014 | 22 | 31 |
| 2015 | 18 | 29 |
| 2016 | 30 | 35 |
| 2017 | 27 | 39 |
| 2018 | 19 | 19 |
| 2019 | 20 | 29 |
| 2020 | 20 | 27 |
| 2021 | 16 | 26 |
| 2022 | 24 | 25 |
| 2023 | 12 | 32 |
| 2024 | 17 | 37 |
| 2025 | 15 | 29 |
| 2026 | 8 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Compound, corrosion inhibitor, and lubricant composition15 Sep 2026US 12,735,393 B2Idemitsu Kosan Co., Ltd.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- Curcusone diterpenoids and uses thereof5 May 2026US 12,617,745 B2Purdue Research Foundation
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same1 Oct 2026US 2026/0297073 A1Chong Kun Dang Pharmaceutical Corp.
- Chromophoric compounds and uv-absorbing compositions10 Sep 2026US 2026/0265181 A1Lygg Corporation
- Use of labeled inhibitors of prostate specific membrane antigen (psma), as agents for the treatment of prostate cancer3 Sep 2026US 2026/0256957 A1Novartis AG
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Modulators of ATP-Binding Cassette transporters109US 7,973,169 B2Vertex Pharmaceuticals Incorporated · 2011
- Orally active heparin salts containing multivalent cationic units101US 4,703,042 A1987
- Glycinamides as factor Xa inhibitors93US 7,115,627 B2Bristol-Myers Squibb Company · 2006